Lifestyle Intervention in the Memory Clinics of General and Academic Hospitals Trial
Launched by MAASTRICHT UNIVERSITY MEDICAL CENTER · Feb 12, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The LIGHT trial is studying how lifestyle changes can help older adults who have early signs of memory problems, known as subjective cognitive decline (SCD) or mild cognitive impairment (MCI). The goal is to see if a tailored lifestyle intervention can reduce the risk of developing dementia. In this study, 300 participants aged 50 and older will be divided into two groups: one group will receive personalized coaching on healthy habits, along with support to help them manage their lifestyle changes, while the other group will get general health advice for a year.
To be eligible for this trial, participants must be at least 50 years old and have either SCD or MCI, along with two or more factors that can be changed to reduce dementia risk. However, individuals with a dementia diagnosis or certain other health conditions cannot participate. Those who join the trial can expect to receive guidance on improving their health and memory over the year. This study is currently recruiting participants, and it aims to help us understand if lifestyle changes can truly make a difference in memory and cognitive health as we age.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ≥50 years of age at pre-screening;
- • Having a diagnosis of SCD or MCI;
- • Presence of ≥ 2 modifiable risk factors for dementia.
- Exclusion Criteria:
- • Having a diagnosis of dementia;
- • Insufficient understanding of the Dutch language;
- • Conditions affecting safe and continuous engagement in the intervention (e.g. under treatment for current malignant diseases, major psychiatric disorders (e.g. major depression, psychosis, bipolar disorder), other conditions preventing co-operation as judged by the local study nurse or consulted physician at the local study site;
- • Participation in any other research intervention trial at time of pre-screening and throughout the study period.
About Maastricht University Medical Center
Maastricht University Medical Center (MUMC+) is a leading academic medical center in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, MUMC+ integrates cutting-edge scientific inquiry with clinical practice, focusing on a wide range of medical disciplines. The center emphasizes collaboration among multidisciplinary teams, fostering an environment that promotes excellence in patient care and the translation of research findings into clinical applications. MUMC+ is dedicated to improving health outcomes and enhancing quality of life through rigorous clinical investigations and the development of novel therapeutic strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Maastricht, , Netherlands
Amsterdam, , Netherlands
Patients applied
Trial Officials
Sebastian Köhler, Professor
Principal Investigator
Maastricht University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported